Not quite the news we’re all waiting for, but none the less an extra two years of patent life in the US should increase the value and attractiveness of PD1-Vaxx for any licensing deal negotiations.
Ann: Imugene PD1-Vaxx patent extended to 2040, page-2
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $220.0K | 4.512M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 45420 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 4779371 | 27 |
View Market Depth
| Last trade - 11.19am 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |